Don't know much about how these things work, but been wondering about this molecule. Could it be some of the reason for why salt water infusions give some patients some symptom relief - by diluting the blood and lessen it's impact....?
Speculation ahead:
Fluge and Mella thought that it was the
concentration of some unknown factor in the blood ("X") that produced symptoms. Below a certain concentration of "X" in the blood, symptoms abated. They reasoned that the patients who responded most quickly to Rituximab were those whose levels of "X" were not much above the response threshold to begin with. Maybe they were right about "X," but wrong about Rituximab's ability to influence it.
As you say, one way to reduce the
concentration of "X" in the blood without reducing the
amount of "X" in the blood is to increase the blood volume, thereby diluting "X."
So, might an infusion, any infusion, into the bloodstream be enough to temporarily reduce the concentration of "X" and ease symptoms? The answer might vary from patient to patient depending on their initial concentration of "X." If it's already quite high, an infusion might not reduce the concentration enough to make any difference.
Dr. Bell has reported temporary improvement in some patients who simply got saline or a blood transfusion. I'm also reminded of
Dr. Stephen Straus' acyclovir trial in which subjects and controls not only received infusions of the drug, but also received substantial infusions of saline to ward off drug induced kidney damage. Both subjects and controls reported similar numbers and degrees of improvement, showing that acyclovir was not the cause of that improvement. Then what was? It was written off as a placebo effect - but both patients and controls would have had their blood volume expanded equally. The "responders" might have simply had lower concentrations of "X" to begin with.
I'm not sure how long the blood volume remains expanded after an infusion. Normally, I'd assume it would be eliminated through the kidneys pretty quickly. The situation might be different if patients actually
already had low blood volume, as has sometimes been reported. It might take longer to go from
normal back to subnormal than it takes to go from
above-normal back to normal.
Which raises another question. Could some patients have a "normal" amount of "X" for a healthy person, but yet are symptomatic because their low blood volume increases their concentration of "X?"